{
    "title": "AstraZeneca focus to be on R&D after a team shake-up",
    "url": "https://www.dailymail.co.uk/money/markets/article-2262847/AstraZeneca-focus-R-D-team-shake-up.html",
    "date": "2013-01-15",
    "keywords": [
        "team",
        "executive",
        "management",
        "focus",
        "rd",
        "soriot",
        "research",
        "development",
        "head",
        "time",
        "pipeline",
        "shakeup",
        "mail",
        "gmt",
        "email",
        "view",
        "broom",
        "chief",
        "revamp",
        "astrazenecas",
        "heart",
        "move",
        "boss",
        "martin",
        "mackay",
        "zook",
        "exit",
        "decision",
        "layer",
        "group",
        "life",
        "product",
        "astrazeneca",
        "october",
        "discovery",
        "stage",
        "latestage",
        "regionscenkos",
        "analyst",
        "malik",
        "surprise",
        "leavinghe",
        "pfizer",
        "heavyhitter",
        "board",
        "lot",
        "announcement",
        "review",
        "brennan",
        "shareholder",
        "revolt",
        "firm",
        "report",
        "structure",
        "decisionmakinghis",
        "company",
        "share",
        "speculation",
        "city",
        "money",
        "series",
        "bolton",
        "impact",
        "patent",
        "quarter",
        "cent",
        "period",
        "departmentsoriot",
        "year",
        "bonus",
        "salary",
        "hello",
        "loss",
        "incentive",
        "plan",
        "employer",
        "roche"
    ],
    "category": [
        "money",
        "markets"
    ]
}